153 related articles for article (PubMed ID: 36577966)
1. Clinical value and potential mechanisms of BUB1B up-regulation in nasopharyngeal carcinoma.
Qin LT; Huang SW; Huang ZG; Dang YW; Fang YY; He J; Niu YT; Lin CX; Wu JY; Wei ZX
BMC Med Genomics; 2022 Dec; 15(1):272. PubMed ID: 36577966
[TBL] [Abstract][Full Text] [Related]
2. Integrated analysis of multiple gene expression profiling datasets revealed novel gene signatures and molecular markers in nasopharyngeal carcinoma.
Huang C; Tang H; Zhang W; She X; Liao Q; Li X; Wu M; Li G
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):166-75. PubMed ID: 22068284
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of MicroRNA-1 and Its Potential Molecular Mechanism in Nasopharyngeal Cancer: An Investigation Combined with In Silico and In-House Immunohistochemistry Validation.
Wen JY; Qin LT; Chen G; Huang HQ; Shen MJ; Pang JS; Tang YX; Lu W; Wang RS; Luo JY
Dis Markers; 2022; 2022():7962220. PubMed ID: 35251377
[TBL] [Abstract][Full Text] [Related]
4. Differentially Expressed Genes in Nasopharyngeal Carcinoma Tissues and Their Correlation with Recurrence and Metastasis of Nasopharyngeal Carcinoma.
Yue H; Zhu H; Luo D; Du Q; Xie Y; Huang S; Liu W
Comput Math Methods Med; 2022; 2022():1941412. PubMed ID: 35509856
[TBL] [Abstract][Full Text] [Related]
5. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
Liu M; Zhu K; Qian X; Li W
Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of
Zeng Q; Zhang S; He L; Fu Q; Liao L; Chen L; Ding X
Cancer Biother Radiopharm; 2024 Apr; 39(3):236-246. PubMed ID: 37782908
[No Abstract] [Full Text] [Related]
7. Identification of key pseudogenes in nasopharyngeal carcinoma based on RNA-Seq analysis.
Zhang X; Song X; Lai Y; Zhu B; Luo J; Yu H; Yu Y
BMC Cancer; 2021 Apr; 21(1):483. PubMed ID: 33931030
[TBL] [Abstract][Full Text] [Related]
8. BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway.
Qiu J; Zhang S; Wang P; Wang H; Sha B; Peng H; Ju Z; Rao J; Lu L
Cancer Med; 2020 Nov; 9(21):8159-8172. PubMed ID: 32977361
[TBL] [Abstract][Full Text] [Related]
9. A Pan-Cancer Analysis of the Immunological and Prognostic Role of BUB1 Mitotic Checkpoint Serine/Threonine Kinase B (BUB1B) in Human Tumors.
Huang W; Chen Z; Tang Y; Li J; Fan L
Clin Lab; 2024 Jan; 70(1):. PubMed ID: 38213208
[TBL] [Abstract][Full Text] [Related]
10. High expression of WTAP is related to poor prognosis in nasopharyngeal carcinoma.
Tao CJ; Zhang P; Chen YY; Chen M
Neoplasma; 2023 Apr; 70(2):229-239. PubMed ID: 36964720
[TBL] [Abstract][Full Text] [Related]
11. Splicing factor derived circular RNA circCAMSAP1 accelerates nasopharyngeal carcinoma tumorigenesis via a SERPINH1/c-Myc positive feedback loop.
Wang Y; Yan Q; Mo Y; Liu Y; Wang Y; Zhang S; Guo C; Wang F; Li G; Zeng Z; Xiong W
Mol Cancer; 2022 Feb; 21(1):62. PubMed ID: 35227262
[TBL] [Abstract][Full Text] [Related]
12. Silencing of long noncoding RNA SRRM2-AS exerts suppressive effects on angiogenesis in nasopharyngeal carcinoma via activating MYLK-mediated cGMP-PKG signaling pathway.
Chen S; Lv L; Zhan Z; Wang X; You Z; Luo X; You H
J Cell Physiol; 2020 Nov; 235(11):7757-7768. PubMed ID: 31742692
[TBL] [Abstract][Full Text] [Related]
13. Opa interacting protein 5 promotes metastasis of nasopharyngeal carcinoma cells by promoting EMT via modulation of JAK2/STAT3 signal.
Zheng YQ; Cui YR; Yang S; Wang YP; Qiu YJ; Hu WL
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):613-621. PubMed ID: 30720169
[TBL] [Abstract][Full Text] [Related]
14. Tubulin polymerization promoting protein family member 3 (TPPP3) overexpression inhibits cell proliferation and invasion in nasopharyngeal carcinoma.
Su Q; Yang Z; Guo X; Mo W; Li X
Bioengineered; 2021 Dec; 12(1):8485-8495. PubMed ID: 34668461
[TBL] [Abstract][Full Text] [Related]
15. Over-expression of BCAT1, a c-Myc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma.
Zhou W; Feng X; Ren C; Jiang X; Liu W; Huang W; Liu Z; Li Z; Zeng L; Wang L; Zhu B; Shi J; Liu J; Zhang C; Liu Y; Yao K
Mol Cancer; 2013 Jun; 12():53. PubMed ID: 23758864
[TBL] [Abstract][Full Text] [Related]
16. FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway.
Chen CH; Shiu LY; Su LJ; Huang CY; Huang SC; Huang CC; Yin YF; Wang WS; Tsai HT; Fang FM; Chuang WC; Kang HC; Hwang CF
J Transl Med; 2012 May; 10():93. PubMed ID: 22591637
[TBL] [Abstract][Full Text] [Related]
17. Anticancer targets and mechanisms of calycosin to treat nasopharyngeal carcinoma.
Liu F; Pan Q; Wang L; Yi S; Liu P; Huang W
Biofactors; 2020 Jul; 46(4):675-684. PubMed ID: 32449282
[TBL] [Abstract][Full Text] [Related]
18. Homeodomain protein DLX4 facilitates nasopharyngeal carcinoma progression via up-regulation of YB-1.
Ling Z; Long X; Li J; Feng M
Genes Cells; 2020 Jul; 25(7):466-474. PubMed ID: 32281175
[TBL] [Abstract][Full Text] [Related]
19. BUB1B (BUB1 Mitotic Checkpoint Serine/Threonine Kinase B) promotes lung adenocarcinoma by interacting with Zinc Finger Protein ZNF143 and regulating glycolysis.
Zhou X; Yuan Y; Kuang H; Tang B; Zhang H; Zhang M
Bioengineered; 2022 Feb; 13(2):2471-2485. PubMed ID: 35068350
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the prognostic value of TGF-β superfamily type I receptor and TGF-β type II receptor expression in nasopharyngeal carcinoma using high-throughput tissue microarrays.
Zhang W; Zeng Z; Fan S; Wang J; Yang J; Zhou Y; Li X; Huang D; Liang F; Wu M; Tang K; Cao L; Li X; Xiong W; Li G
J Mol Histol; 2012 Jun; 43(3):297-306. PubMed ID: 22391627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]